Volume 25, Issue 3 (May 2023) 25, 433–434; 10.4103/aja202277
Germline mutations in 5’ to c.7914 of BRCA2 significantly increase risk of prostate cancer
Ruan, Xiao-Hao1,*; Huang, Da1,*; Lin, Xiao-Ling2; Fang, Zu-Jun2; Ding, Qiang2; Wu, Yi-Shuo2,; Na, Rong3
1Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China; 2Department of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China; 3Division of Urology, Department of Surgery, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
Correspondence: Dr. R Na (firstname.lastname@example.org) or Dr. YS Wu (email@example.com)
Received: 26 June 2022; Accepted: 01 September 2022; published online: 28 October 2022